I interviewed Ruch Horgan who lost his younger brother to a rare
disease last year and we talked about a different approach to
developing new therapies for rare and ultra rare disease
patients.
We are at a watershed moment in healthcare. The entire industry is being compelled to question old assumptions and chart a new path forward - in a word, we need to pivot. This podcast hosted by the editorial team at MedCity News will highlight the strategies, the companies and the personalities spearheading this monumental transformation.